| Case Series |
Mao, et al. (China) |
Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. |
| Wang, et al. (China) |
Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. |
| Young, et al. (EUA) |
Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. |
| Wu, et al. (China. March 2020) |
Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. |
| Bordi, et al. (Italia. February 2020) |
Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2) |
| Shen, et al. (China. March 2020) |
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. |
| Yang, et al. (China, 2020) |
Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): A multi-center study in Wenzhou city, Zhejiang, China. |
| Liu, et al. (China, March 2020) |
CT manifestations of coronavirus disease-2019: a retrospective analysis of 73 cases by disease severity. |
| Huang, et al. (China) |
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China |
| Wang, et al. (China) |
The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China. |
| Kong, et al. South Korea |
Early Epidemiological and Clinical Characteristics of 28 Cases of Coronavirus Disease in South Korea. |
| Cohort |
Linton, et al. (China. February 2020) |
Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation |
| Guan, et al. |
Clinical Characteristics of Coronavirus Disease 2019 in China. |
| Wu, et al. (China. March 2020) |
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. |
| Zhou, et al. (China) |
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. |
| Non-randomized Clinical Trial |
Gautret, et al. (France. March 2020) |
Hydroxychloroquine and Azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. |
| Review Article |
Lipsitch, et al. (EUA. February 2020) |
Defining the Epidemiology of Covid-19 — Studies Needed. |
| Rothan, et al. (February 2020) |
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. |
| Lai, et al (February 2020) |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. |
| Wu, et al (February 2020) |
The SARS-CoV2 Outbreak: WhatsApp se know. International Journal of Infectious Diseases. |
| Thomas-Rüddel, et al. (Germany. March 2020) |
Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020. |
| Chen, et al. (February 2020) |
Convalescent plasma as a potential therapy for COVID-19. |
| Jiang, et al. (March 2020) |
Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). |
